2025’s Gene Therapy Breakthroughs Show the Future of Genomics in Action A new era of precision medicine is taking shape with remarkable speed, and few recent developments exemplify this better than the success of CRISPR-based and gene therapy interventions for rare...
InGeNA CEO Appointed to Genomics Australia Advisory Council We’re proud to share that InGeNA CEO Dr Erin Evans has been appointed as one of seven individual members of the newly formed Genomics Australia Advisory Council, chaired by the Genomics Commissioner Tiffany...
InGeNA Submission on the Ban of Genetic Discrimination The Industry Genomics Network Alliance (InGeNA) has made a submission to the Treasury Laws Amendment (Genetic Discrimination) Bill 2025 consultation, representing the collective voice of Australia’s genomics and...
Every patient responds differently to medication. For some, a standard dose offers relief; for others, the same medication may cause adverse effects or offer no benefit at all. Pharmacogenomics – an essential pillar of precision medicine – aims to change this by...
Precision medicine, also referred to as personalised medicine, represents a transformative approach in healthcare, tailoring medical treatment to the individual characteristics of each patient. Central to this paradigm is genomics – the comprehensive study of an...
